Lj. Balcer et al., Self-reported visual dysfunction in multiple sclerosis: results from the 25-Item National Eye Institute Visual Function Questionnaire (VFQ-25), MULT SCLER, 6(6), 2000, pp. 382-385
Visual impairment is one of the most common clinical manifestations of Mult
iple Sclerosis (MS), and is strongly related to overall health-related qual
ity of life (HRQOL) in MS and other disorders. However, the assessment of v
ision-specific HRQOL in patients with MS has been limited. The purpose of t
his study was to examine self-reported visual dysfunction in a clinically h
eterogeneous MS cohort using the 25-item Notional Eye Institute Visual Func
tion Questionnaire (VFQ-25). The VFQ-25 was administered by telephone inter
view to a subset of participants in a follow-up study to a phase ill trial
of interferon P-fa for relapsing-remitting MS. Mean VFQ-25 composite scores
and selected sub-scale scores were significantly lower (worse) among patie
nts in our MS cohort (n=35) compared with a published reference group of pa
tients with no history of chronic eye disease n=118). These differences wer
e observed despite a relatively younger age and tighter distribution of bin
ocular visual acuities in the MS cohort Patients with MS in this study thus
demonstrated a greeter degree of self-reported visual dysfunction, as meas
ured by the VFQ-25, compared with an eye disease-free reference group. The
VFQ-25 is a potentially useful measure of vision-specific HRQOL in patients
with MS.